APLS

Apellis Pharmaceuticals Inc (APLS)

US
$ 17.42-5.89%

Price Chart

Key Statistics

Market Cap
$ 2.45B
P/E Ratio
0.00
Revenue (TTM)
$ 775.84M
Volume
1.79M
52W High
$ 42.47
52W Low
$ 16.10
Dividend Yield
0.00%
Beta
0.67

Technicals

50-Day MA
18.1816
200-Day MA
25.4486
52 Week High
42.47
52 Week Low
16.1

About APLS

Apellis Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of novel therapeutic compounds to treat diseases with high unm.

Employees
705
Headquarters
Waltham, MA
CEO
Dr. Cedric Francois M.D., Ph.D.

Latest News

Advanced Charts

Access professional-grade trading charts and technical analysis tools

Top Gainers

Symbol/Name
LTP
% Chg
JELD
JELD-WEN Holding In...
$ 4.40
12.24
LVS
Las Vegas Sands Cor...
$ 47.36
8.87
CCS
Century Communities...
$ 61.22
8.70
KTB
Kontoor Brands Inc....
$ 71.65
8.61
BBWI
Bath & Body Works I...
$ 32.40
8.14

Top Losers

Symbol/Name
LTP
% Chg
ACHR
Archer Aviation Inc...
$ 9.97
-8.11
AMC
AMC Entertainment H...
$ 2.87
-7.42
OKLO
Oklo Inc.
$ 52.29
-6.58
QS
QuantumScape Corpor...
$ 6.29
-6.40
SE
Sea Limited America...
$ 150.49
-5.96